STOCK TITAN

Curaleaf (OTCQX: CURLF) schedules Feb. 26 call on 2025 results

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Curaleaf Holdings, Inc. has scheduled the release of its fourth quarter and full year 2025 financial and operating results for after market close on February 26, 2026. Management will discuss the results on a conference call and webcast that day at 5:00 p.m. ET, followed by a question-and-answer session.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2026
Commission File Number: 333-249081
Curaleaf Holdings, Inc.
(Name of Registrant)
666 Burrard Street, Suite 1700,
Vancouver, British Columbia V6C 2X8, Canada
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐    Form 40-F ☒



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CURALEAF HOLDINGS, INC.
(Registrant)
Date:February 2, 2026By:/s/ Peter Clateman
Name:Peter Clateman
Title:Chief Legal Officer



EXHIBIT INDEX

Exhibit NumberDescription
99.1
Press Release

Curaleaf Holdings, Inc. Investor Relations Curaleaf to Report Fourth Quarter and Full Year 2025 Financial and Operational Results STAMFORD, Conn., Jan. 28, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the fourth quarter and full year ended December 31, 2025 after market close on February 26, 2026. Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights. Event: Curaleaf Fourth Quarter and Full Year 2025 Financial Earnings Conference Call Date: Thursday, February 26, 2026 Time: 5:00 p.m. ET Live Call: +1-844-512-2926 (North America) or +1-412-317-6300 (International) Passcode: 3667642 Webcast: https://ir.curaleaf.com/events For interested individuals unable to join the conference call, a dial-in replay of the call will be available until March 5, 2026, and can be accessed by dialing +1-855-669-9658 (North America) or +1-412-317-0088 (International) and entering replay pin number: 1190273. About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Dark Heart, Anthem, JAMS, and Find provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com. Curaleaf IR X Account: https://x.com/Curaleaf_IR Investor Relations Website: https://ir.curaleaf.com/ Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer IR@curaleaf.com Media Contact: MATTIO Communications MattioCuraleaf@Mattio.com SOURCE Curaleaf Holdings, Inc. https://ir.curaleaf.com/2026-01-28-Curaleaf-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operational-Results


 

FAQ

When will Curaleaf (CURLF) report its Q4 and full-year 2025 results?

Curaleaf will report its fourth quarter and full-year 2025 financial and operating results after market close on February 26, 2026. The company will also host a conference call and webcast that afternoon to review performance and take questions from participants.

What time is Curaleaf's Q4 and full-year 2025 earnings conference call?

The Curaleaf Q4 and full-year 2025 earnings conference call is scheduled for 5:00 p.m. ET on Thursday, February 26, 2026. Management will provide prepared remarks on operational and financial highlights, followed by a live question-and-answer session with call participants.

How can investors access Curaleaf's February 26, 2026 earnings call?

Investors can join Curaleaf’s earnings call by dialing +1-844-512-2926 in North America or +1-412-317-6300 internationally using passcode 3667642. A simultaneous audio webcast will be available at https://ir.curaleaf.com/events for convenient online listening.

Will a replay be available for Curaleaf's Q4 and 2025 results call?

Yes. A dial-in replay of Curaleaf’s earnings call will be available until March 5, 2026 by calling +1-855-669-9658 in North America or +1-412-317-0088 internationally and entering replay PIN 1190273 for access.

Where can investors find more information on Curaleaf (CURLF)?

Investors can learn more about Curaleaf by visiting its investor relations website at https://ir.curaleaf.com. The company also shares updates through the Curaleaf IR X account at https://x.com/Curaleaf_IR, alongside news releases and corporate disclosures.

What does Curaleaf Holdings do in the cannabis market?

Curaleaf Holdings is described as a leading international provider of consumer products in cannabis. Its brands, including Curaleaf, Select, Grassroots and others, offer products and services across medical and adult-use markets in North America and Europe.

Curaleaf Hldgs

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Latest SEC Filings

CURLF Stock Data

1.94B
616.07M
27.84%
2.12%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Stamford